Europeans clear fast track for swine flu vax

Determined to head off a swine flu pandemic that is once again inspiring widespread fear, the European Medicines Agency has cleared a fast track for the development of a new vaccine, doing away with the need for large-scale human trials. Following a development format originally laid out in the event bird flu started to spread in humans, vaccine makers will be able to start providing the first doses of their new vaccines as early as next month. Report

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.